OptimizeRx Corporation announced that As previously announced, Ed Stelmakh has joined OptimizeRx in the combined role of Chief Financial Officer and Chief Operational Officer. Ed hit the ground running and he is getting up to speed with a focus on developing the right KPIs that best represent position and prospects in the marketplace, as well as making sure have the systems and processes in place to continue scaling business. Effective December 31, 2021, Miriam Paramore will be retiring from her full-time position as President and Chief Strategy Officer and transitioning to an advisory role to the leadership team. Through careful succession planning, all of her functions have been fully transitioned to other members of the executive team. Going forward, the Company’s executive leadership team will be comprised of myself, Ed Stelmakh, Steve Silvestro, Todd Inman and Marion Odence-Ford.